BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 142 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2017. The put-call ratio across all filers is 0.76 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $10,089,000 | +69.3% | 106,956 | +43.7% | 0.92% | +73.9% |
Q1 2019 | $5,960,000 | +56.1% | 74,451 | +52.2% | 0.53% | +73.9% |
Q3 2018 | $3,819,000 | +21.9% | 48,921 | -0.9% | 0.31% | +39.1% |
Q2 2018 | $3,133,000 | -1.1% | 49,362 | +42.8% | 0.22% | -3.1% |
Q1 2018 | $3,169,000 | -44.3% | 34,556 | -54.2% | 0.23% | +20.7% |
Q4 2017 | $5,694,000 | +118.6% | 75,510 | +101.9% | 0.19% | +4.4% |
Q3 2017 | $2,605,000 | +37.6% | 37,394 | +0.2% | 0.18% | +34.3% |
Q2 2017 | $1,893,000 | +115.6% | 37,337 | +69.7% | 0.13% | +116.1% |
Q1 2017 | $878,000 | – | 21,998 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
SIB LLC | 65,151 | $6,335,000 | 3.72% |
CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |